"UPMC Hillman Cancer Center (Medical Oncology) is a cancer treatment center located in New Castle.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Hillman Cancer Center - New Castle conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Hillman Cancer Center - New Castle" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "University of Pittsburgh" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Ahmad Tarhini" with 1 trials sponsored and "Alliance for Clinical Trials in Oncology" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center - New Castle" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center - New Castle" are "Stage IIIA Lung Cancer AJCC v8" (2 trials), "Stage IIIB Lung Cancer AJCC v8" (2 trials), "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials) and "ALK Positive" (1 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center - New Castle" in a lesser frequency.

Most popular intervention types in "UPMC Hillman Cancer Center - New Castle" are "Drug" (15 trials), "Other" (8 trials), "Biological" (7 trials), "Procedure" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (5 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials), "Atezolizumab" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Hillman Cancer Center - New Castle" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Hillman Cancer Center - New Castle". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in UPMC Hillman Cancer Center - New Castle, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Hillman Cancer Center - New Castle, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".